Effect of Inderal with and without Rosuvastatin on migraine attacks

Effect of Inderal with and without Rosuvastatin on migraine attacks: A triple blind randomized clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N267

Enrollment

120

Registered

2019-03-24

Start date

2019-04-21

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Migraine

Interventions

Intervention 1: Intervention group: One tablet of Inderal 10 mg every 12 hours plus one tablet of Rosuvastatin 10 mg at evening for one month. Intervention 2: Control group: One tablet of Inderal 10 m

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age of 18 to 65 years; Migraine; Serum level of LDL between 150 to 160 mg/dl

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding; Liver or renal failure; Memory impairment

Design outcomes

Primary

Measure	Time frame
Number of migraine attacks. Timepoint: At the end of the first, second, third, and fourth weeks. Method of measurement: By history taking.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReihaneh Mahmoodian

Hamedan University of Medical Sciences

reihan7mah@yahoo.com+98 81 3827 4184

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026